BULLFROG AI HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
BULLFROG AI HOLDINGS, INC. (BFRG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 15.25 thousand shares for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-05-14
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 15.25K shares, a 85.52% decline year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 137.63K shares, a 238.18% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 117.52K shares, a 221.98% increase year-over-year.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-06-30 was 0.00 shares.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 360.45K shares, a 314.37% increase from fiscal 2024.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 86.99K shares.
- BULLFROG AI HOLDINGS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 399.35K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-03-31 | 15.25K shares 10-Q · filed 2026-05-14 | 152.88K shares derived: sum of 2 quarters · filed 2026-05-14 | 270.39K shares derived: sum of 3 quarters · filed 2026-05-14 | 270.39K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-12-31 | 137.63K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 255.14K shares derived: sum of 2 quarters · filed 2026-03-19 | 255.14K shares derived: sum of 3 quarters · filed 2026-03-19 | 360.45K shares 10-K · filed 2026-03-19 |
| 2025-09-30 | 117.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 117.52K shares derived: sum of 2 quarters · filed 2025-11-14 | 222.82K shares 10-Q · filed 2025-11-14 | 263.51K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | 105.30K shares 10-Q · filed 2025-08-13 | 146.00K shares derived: sum of 3 quarters · filed 2026-05-14 | 182.50K shares derived: sum of 4 quarters · filed 2026-05-14 |
| 2025-03-31 | 105.30K shares 10-Q · filed 2026-05-14 | 146.00K shares derived: sum of 2 quarters · filed 2026-05-14 | 182.50K shares derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | 40.70K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | 77.19K shares derived: sum of 2 quarters · filed 2026-03-19 | 86.99K shares 10-K · filed 2026-03-19 | |
| 2024-09-30 | 36.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | 46.29K shares 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | 9.79K shares 10-Q · filed 2025-08-13 | |||
| 2022-12-31 | 399.35K shares 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |